Contrast Acuity With Different Colors in Parkinson's Disease

Harsh V. Gupta, Nan Zhang, Erika M Driver-Dunckley, Shyamal Mehta, Thomas G. Beach, Charles Howard Adler

Research output: Contribution to journalArticle

Abstract

Background: Abnormal color vision and contrast acuity may have significant impact on daily activities. Objective: Evaluate color visual acuity, at high and low contrast, in Parkinson's disease (PD) and controls using an iPad application. Methods: Color visual acuity was tested with the Variable Contrast Acuity Chart (King-Devick Test LLC, Oakbrook Terrace, IL) on an iPad 2 at 40 cms using five colors (red, green, blue, yellow, and black) at low (2.5%) and high (100%) contrast. A numerical score (0–95) was assigned based on the number of correctly identified letters. Results: Thirty-six PD (mean ± standard deviation age 68 ± 10 years) and 36 controls (72 ± 11.2 years) were studied. PD disease duration was 6.4 ± 4.6 years; MDS-UPDRS part II was 11.7 ± 7.0, and part III was 24.5 ± 9.9. After adjusting for age and sex, PD patients had significantly (P < 0.05) lower scores at high (100%) as well as low (2.5%) contrast for all five colors tested (red, green, blue, yellow, and black), except yellow low contrast (2.5%; P = 0.10). The largest effect size (0.88) was with yellow high contrast, and the sensitivity, specificity, positive predictive value, negative predictive value, and accuracy using a cut-off score of 82 was 31%, 97%, 92%, 58%, and 64%, respectively. No correlation to disease duration was found. Conclusions: This iPad application may be a simple-to-use biomarker for assessing color vision in PD. Further research is needed to determine disease specificity and whether there is a role in monitoring disease progression, treatment response, and identifying prodromal PD.

Original languageEnglish (US)
JournalMovement Disorders Clinical Practice
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Parkinson Disease
Color
Color Vision
Visual Acuity
Contrast Sensitivity
Disease Progression
Biomarkers
Sensitivity and Specificity
Research

Keywords

  • contrast sensitivity
  • King-Devick test
  • Parkinson's disease
  • visual acuity

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Contrast Acuity With Different Colors in Parkinson's Disease. / Gupta, Harsh V.; Zhang, Nan; Driver-Dunckley, Erika M; Mehta, Shyamal; Beach, Thomas G.; Adler, Charles Howard.

In: Movement Disorders Clinical Practice, 01.01.2019.

Research output: Contribution to journalArticle

@article{538f822d89a84e65be2a1c97e4daf4f8,
title = "Contrast Acuity With Different Colors in Parkinson's Disease",
abstract = "Background: Abnormal color vision and contrast acuity may have significant impact on daily activities. Objective: Evaluate color visual acuity, at high and low contrast, in Parkinson's disease (PD) and controls using an iPad application. Methods: Color visual acuity was tested with the Variable Contrast Acuity Chart (King-Devick Test LLC, Oakbrook Terrace, IL) on an iPad 2 at 40 cms using five colors (red, green, blue, yellow, and black) at low (2.5{\%}) and high (100{\%}) contrast. A numerical score (0–95) was assigned based on the number of correctly identified letters. Results: Thirty-six PD (mean ± standard deviation age 68 ± 10 years) and 36 controls (72 ± 11.2 years) were studied. PD disease duration was 6.4 ± 4.6 years; MDS-UPDRS part II was 11.7 ± 7.0, and part III was 24.5 ± 9.9. After adjusting for age and sex, PD patients had significantly (P < 0.05) lower scores at high (100{\%}) as well as low (2.5{\%}) contrast for all five colors tested (red, green, blue, yellow, and black), except yellow low contrast (2.5{\%}; P = 0.10). The largest effect size (0.88) was with yellow high contrast, and the sensitivity, specificity, positive predictive value, negative predictive value, and accuracy using a cut-off score of 82 was 31{\%}, 97{\%}, 92{\%}, 58{\%}, and 64{\%}, respectively. No correlation to disease duration was found. Conclusions: This iPad application may be a simple-to-use biomarker for assessing color vision in PD. Further research is needed to determine disease specificity and whether there is a role in monitoring disease progression, treatment response, and identifying prodromal PD.",
keywords = "contrast sensitivity, King-Devick test, Parkinson's disease, visual acuity",
author = "Gupta, {Harsh V.} and Nan Zhang and Driver-Dunckley, {Erika M} and Shyamal Mehta and Beach, {Thomas G.} and Adler, {Charles Howard}",
year = "2019",
month = "1",
day = "1",
doi = "10.1002/mdc3.12821",
language = "English (US)",
journal = "Movement Disorders Clinical Practice",
issn = "2330-1619",
publisher = "John Wiley and Sons Ltd",

}

TY - JOUR

T1 - Contrast Acuity With Different Colors in Parkinson's Disease

AU - Gupta, Harsh V.

AU - Zhang, Nan

AU - Driver-Dunckley, Erika M

AU - Mehta, Shyamal

AU - Beach, Thomas G.

AU - Adler, Charles Howard

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Background: Abnormal color vision and contrast acuity may have significant impact on daily activities. Objective: Evaluate color visual acuity, at high and low contrast, in Parkinson's disease (PD) and controls using an iPad application. Methods: Color visual acuity was tested with the Variable Contrast Acuity Chart (King-Devick Test LLC, Oakbrook Terrace, IL) on an iPad 2 at 40 cms using five colors (red, green, blue, yellow, and black) at low (2.5%) and high (100%) contrast. A numerical score (0–95) was assigned based on the number of correctly identified letters. Results: Thirty-six PD (mean ± standard deviation age 68 ± 10 years) and 36 controls (72 ± 11.2 years) were studied. PD disease duration was 6.4 ± 4.6 years; MDS-UPDRS part II was 11.7 ± 7.0, and part III was 24.5 ± 9.9. After adjusting for age and sex, PD patients had significantly (P < 0.05) lower scores at high (100%) as well as low (2.5%) contrast for all five colors tested (red, green, blue, yellow, and black), except yellow low contrast (2.5%; P = 0.10). The largest effect size (0.88) was with yellow high contrast, and the sensitivity, specificity, positive predictive value, negative predictive value, and accuracy using a cut-off score of 82 was 31%, 97%, 92%, 58%, and 64%, respectively. No correlation to disease duration was found. Conclusions: This iPad application may be a simple-to-use biomarker for assessing color vision in PD. Further research is needed to determine disease specificity and whether there is a role in monitoring disease progression, treatment response, and identifying prodromal PD.

AB - Background: Abnormal color vision and contrast acuity may have significant impact on daily activities. Objective: Evaluate color visual acuity, at high and low contrast, in Parkinson's disease (PD) and controls using an iPad application. Methods: Color visual acuity was tested with the Variable Contrast Acuity Chart (King-Devick Test LLC, Oakbrook Terrace, IL) on an iPad 2 at 40 cms using five colors (red, green, blue, yellow, and black) at low (2.5%) and high (100%) contrast. A numerical score (0–95) was assigned based on the number of correctly identified letters. Results: Thirty-six PD (mean ± standard deviation age 68 ± 10 years) and 36 controls (72 ± 11.2 years) were studied. PD disease duration was 6.4 ± 4.6 years; MDS-UPDRS part II was 11.7 ± 7.0, and part III was 24.5 ± 9.9. After adjusting for age and sex, PD patients had significantly (P < 0.05) lower scores at high (100%) as well as low (2.5%) contrast for all five colors tested (red, green, blue, yellow, and black), except yellow low contrast (2.5%; P = 0.10). The largest effect size (0.88) was with yellow high contrast, and the sensitivity, specificity, positive predictive value, negative predictive value, and accuracy using a cut-off score of 82 was 31%, 97%, 92%, 58%, and 64%, respectively. No correlation to disease duration was found. Conclusions: This iPad application may be a simple-to-use biomarker for assessing color vision in PD. Further research is needed to determine disease specificity and whether there is a role in monitoring disease progression, treatment response, and identifying prodromal PD.

KW - contrast sensitivity

KW - King-Devick test

KW - Parkinson's disease

KW - visual acuity

UR - http://www.scopus.com/inward/record.url?scp=85071838250&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071838250&partnerID=8YFLogxK

U2 - 10.1002/mdc3.12821

DO - 10.1002/mdc3.12821

M3 - Article

AN - SCOPUS:85071838250

JO - Movement Disorders Clinical Practice

JF - Movement Disorders Clinical Practice

SN - 2330-1619

ER -